Ani pharmaceuticals announces the fda approval and launch of estradiol gel, 0.1%

Baudette, minn., aug. 28, 2023 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that it received u.s. food and drug administration (fda) approval for the abbreviated new drug application (anda) for estradiol gel, 0.1%.
ANIP Ratings Summary
ANIP Quant Ranking